RT Journal
A1 Kuehn BM
T1 SCientists probe strategies to repair neuron damage in multiple sclerosis
JF JAMA
JO JAMA
YR 2011
FD March 2
VO 305
IS 9
SP 871
OP 874
DO 10.1001/jama.2011.208
UL http://dx.doi.org/10.1001/jama.2011.208
AB 
Most existing therapies for MS aim to tamp down aberrant immune function and are especially helpful for some phases of the disease, although patients may still progress to a chronic, more progressive stage of illness. In addition, some newer therapies aim to reduce specific symptoms of the disorder. For example, the US Food and Drug Administration recently approved dextromethorphan hydrobromide and quinidine sulfate to treat pseudobulbar affect, a condition marked by uncontrolled emotional outbursts that may develop in patients with MS or certain other neurologic disorders.